The Talents Program

The Talents Program has three key aims:

Further the understanding of the efficacy and mechanisms of action of IGIV in current clinical indications
Explore new clinical uses of IGIV
Support the intellectual endeavors of the IGIV research community.

Grants are awarded on an annual basis and are usually for either a 1- or 2-year period. Grants can include support for salary, overheads and direct costs. Product may also be provided if requested.

The program awards up to $1 million a year. Individual grants can be up to $150,000 per research project per annum, excluding product costs. The maximum funding available per research project is therefore $300,000 awarded over a 2-year period.

The funding cycle takes place on an annual basis. Letters of Intent are reviewed in August, funding is determined in October, and funding begins in January of the following year. See detailed timeline for more information.